Blog
RSS FeedPosted by Michael Wonder on 02 Oct 2024
Schedule of Pharmaceutical Benefits - 1 October 2024
1 October 2024 - The October 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Sep 2024
Cost barriers to medication access in Australia: an analysis of the Patient Experience Survey in context
30 September 2024 - In November 2023, the Australian Bureau of Statistics released its 2022–23 Patient Experience Survey data. ...
Posted by Michael Wonder on 16 Sep 2024
Understanding modelled economic evaluations: a reader's guide for clinicians
26 August 2024 - Economic evaluations have a long history in health care. Full economic evaluations aim to inform decision making ...
Posted by Michael Wonder on 12 Sep 2024
New medicines could be PBS listed in just four weeks under a proposal the health minister calls 'visionary'
11 September 2024 - Have you ever had to wait for an important and expensive medicine to be subsidised? ...
Posted by Michael Wonder on 11 Sep 2024
Final reports of the HTA Policy and Methods Review and Enhanced Consumer Engagement Process
10 September 2024 - The reports of the HTA Review and the Enhanced Consumer Engagement Process have been published. ...
Posted by Michael Wonder on 09 Sep 2024
New and expanded PBS listings for Fabry disease and kidney cancer
9 September 2024 - Australians with Fabry disease, a rare genetic condition, and people with kidney cancer now have access ...
Posted by Michael Wonder on 06 Sep 2024
Agenda for the November 2024 PBAC meeting (version 4)
6 September 2024 - Version 4 of the agenda for the November 2024 PBAC meeting is now available. ...
Posted by Michael Wonder on 02 Sep 2024
Australians save over half a billion dollars on cheaper medicines
1 September 2024 - Thanks to the Albanese Labor Government Australians have saved over half a billion dollars ($525 million) ...
Posted by Michael Wonder on 01 Sep 2024
Cabometyx (cabozantinib) now available for eligible patients with non-clear cell renal cell carcinoma via the PBS
1 September 2024 - Cabometyx (cabozantinib), a once daily oral medication, is now available on the PBS for eligible patients with ...
Posted by Michael Wonder on 31 Aug 2024
Schedule of Pharmaceutical Benefits - 1 September 2024
The September 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Aug 2024
Public Summary Documents – May 2024 PBAC meeting
30 August 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2024 PBAC ...
Posted by Michael Wonder on 30 Aug 2024
Agenda for the September 2024 PBAC intracycle meeting
30 August 2024 - The agenda for the September 2024 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 28 Aug 2024
Life prolonging breast cancer drug receives expanded access on the PBS
28 August 2024 - Australians diagnosed with a type of metastatic breast cancer will now have access to a life ...
Posted by Michael Wonder on 25 Aug 2024
Vulnerable Aussies may remain unprotected against severe RSV
24 August 2024 - There are mounting concerns that Australians at greatest risk of severe respiratory syncytial virus will miss ...
Posted by Michael Wonder on 25 Aug 2024
Recommendations made by the PBAC – July 2024
23 August 2024 - Recommendations made by the PBAC in July 2024 relating to the listing of medicines on the ...